Atypical Pneumonia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Atypical Pneumonia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06684379

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A…

The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obta…

Spain50 participantsStarted 2024-10-02

Treatment: Placebo comparator, PRS CK STORM

All recent trials (11 shown)

Not Yet RecruitingNot Applicable

NCT06727188

Atypical Pneumonia

The goal of this observational study is to learn about causes of unresolved pneumonia in children who take appropriate antimicrobial therapy.

Egypt45 participantsStarted 2025-01-01

Treatment: Laboratory as cbc crp

UnknownNot Applicable

NCT04889326

Collection of the Thrombo-VaxCov Cohort

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect cli…

France100 participantsStarted 2021-04-02

Treatment: Retrospective data and biological samples

Atypical Pneumonia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A…

All recent trials (11 shown)

Atypical Pneumonia

Collection of the Thrombo-VaxCov Cohort

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A…

All recent trials (11 shown)

Atypical Pneumonia

Collection of the Thrombo-VaxCov Cohort

Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HB…

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays

Treatment and Vaccine Development of Mycoplasma Pneumoniae

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia